Efficacy and Safety of Hybutimibe in Combination with Atorvastatin for Treatment of Hypercholesteremia among Patients with Atherosclerotic Cardiovascular Disease Risk Equivalent: A Multicenter, Randomized, Double-Blinded Phase III Study.

Frontiers in Cardiovascular Medicine(2022)

引用 2|浏览47
暂无评分
关键词
atherosclerotic cardiovascular disease risk equivalent,lipid profile,hybutimibe,atorvastatin,randomized controlled trial,cholesterol-absorption inhibitor
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要